SQZ Biotechnologies Co Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SQZ Biotechnologies Co quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2023.
  • SQZ Biotechnologies Co Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $14.4M, a 76.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $14.4M -$48M -76.9% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $22.5M -$42.4M -65.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $24.6M -$42.8M -63.5% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $27.4M -$42.4M -60.7% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 $62.4M -$9.9M -13.7% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $65M +$21.5M +49.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $67.4M +$21.5M +46.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $69.8M +$21.5M +44.4% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $72.3M +$21.5M +42.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $43.5M Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $45.9M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $48.4M +$5.31M +12.3% Dec 31, 2020 10-K 2022-03-16
Q3 2020 $50.8M Sep 30, 2020 10-Q 2020-12-10
Q4 2019 $43.1M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.